初善仪联合阴道镜在宫颈病变筛查中的应用价值  

The value of TruScreen combined electronic colposcope in screening of cervical pathological changes

作　　者：刘玉芳[1] 牛淑芳[1] 郭吉红[1] 冯敏[1] 刘志强[1] 

机构地区：[1]山东省滨州医学院附属医院妇产科,山东滨州256603

出　　处：《现代预防医学》2012年第23期6144-6145,6147,共3页Modern Preventive Medicine

摘　　要：目的探讨初善仪、阴道镜二者联合在宫颈病变筛查中的价值。方法对2011年1～6月在某院因中重度宫颈糜烂行LEEP刀宫颈环切术的患者258例,术前进行初善仪(Truscreen)及电子阴道镜检查,术后切除组织行病理学检查,以病理组织学检查为金标准,分析初善仪联合阴道镜在宫颈病变筛查中的应用价值。结果初善仪检查阳性74例,占28.68%;阴道镜检查阳性82例,占,31.78%,二者符合率211/258,为81.78%。结论初善仪、阴道镜与病理学诊断的一致性均较显著。初善仪与阴道镜联合应用明显提高了宫颈癌及癌前病变的检出率,在临床使用中有重要的价值。OBJECTIVE To investigate the value of TruScreen combined electronic colposcope in screening of cervical disease.METHODS 258 patients who accepted cervical LEEP was involved in our hospital during the first half of the year in 2011.Both TruScreen and electronic colposcope were administered before cervical LEEP,and pathology examination after the operation.The histopathological examination was used as the gold standard to assess the value of the two screening methods.RESULTS The positive rate found with TruScreen was 28.68%（74 patients）,while the positive rate found with electronic colposcope was 31.78%（82 patients）.The consistency rate wan 81.78%（211 /258）.CONCLUSION Both TruScreen and electronic colposcope are in conformity with histopathological examination.The combination of the two methods is more propitious to screen cervical cancer and precancerous lesion.

关 键 词：宫颈癌筛查 初善仪 阴道镜 联合 

分 类 号：R711.74[医药卫生—妇产科学]